April 2024
1. MAURA F, Rajanna AR, Ziccheddu B, Poos AM, et al
   Genomic Classification and Individualized Prognosis in Multiple Myeloma.
   J Clin Oncol. 2024;42:1229-1240.
   

   >> Share

   
   
2. SHRIVER SP, Adams D, McKelvey BA, McCune JS, et al
   Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
   J Clin Oncol. 2024;42:1181-1192.
   

   >> Share

   
   February 2024
3. TRAVIS LB, Feldman DR, Fung C, Poynter JN, et al
   Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship.
   J Clin Oncol. 2024;42:696-706.
   

   >> Share

   
   January 2024
4. RICCIUTI B, Lamberti G, Puchala SR, Mahadevan NR, et al
   Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer.
   J Clin Oncol. 2024 Jan 11:JCO2300580. doi: 10.1200/JCO.23.00580.
   

   >> Share

   
   December 2023
5. JAGSI R, Griffith KA, Harris EE, Wright JL, et al
   Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA.
   J Clin Oncol. 2023 Dec 7:JCO2302270. doi: 10.1200/JCO.23.02270.
   

   >> Share

   
   November 2023
6. MANDELKER D, Marra A, Zheng-Lin B, Selenica P, et al
   Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma.
   J Clin Oncol. 2023;41:5151-5162.
   

   >> Share

   
   
7. KILBRIDE M, Egleston BL, Chung WK, Olopade O, et al
   Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education.
   J Clin Oncol. 2023;41:4905-4915.
   

   >> Share

   
   August 2023
8. NARDONE V, Meirson T, De Felice F, Meattini I, et al
   Genomic Profiling: Can We Rely on Retrospective Analysis to Drive Changes in Clinical Practice?
   J Clin Oncol. 2023;41:3957-3958.
   

   >> Share

   
   
9. ANDO Y, Terada T
   Consent in Pharmacogenetic Testing.
   J Clin Oncol. 2023;41:3875.
   

   >> Share

   
   July 2023
10. STRACH MC, Mahon K, Barriuso J
    Genomic Subtypes of Appendiceal Adenocarcinoma: Enough to Guide Clinical Decision Making?
    J Clin Oncol. 2023;41:3559.
    

    >> Share

    
    June 2023
11. SUBBIAH V, Kurzrock R
    Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis.
    J Clin Oncol. 2023;41:3100-3103.
    

    >> Share

    
    May 2023
12. KINNEY AY, Walters ST, Lin Y, Lu SE, et al
    Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow.
    J Clin Oncol. 2023;41:2767-2778.
    

    >> Share

    
    February 2023
13. CHUNG J, Negm L, Bianchi V, Stengs L, et al
    Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset.
    J Clin Oncol. 2023;41:766-777.
    

    >> Share

    
    January 2023
14. YU Y, Shi Q, Chen H
    Acquired Genomic Alterations From First-Line Anti-EGFR Chemotherapy in Advanced Colorectal Cancer: Improving Study Design and Data Analysis.
    J Clin Oncol. 2023 Jan 3:JCO2202296. doi: 10.1200/JCO.22.02296.
    

    >> Share

    
    December 2022
15. FREY MK, Ahsan MD, Bergeron H, Lin J, et al
    Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.
    J Clin Oncol. 2022;40:4129-4143.
    

    >> Share

    
    September 2022
16. RAGHAV K, Ou FS, Venook AP, Innocenti F, et al
    Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance).
    J Clin Oncol. 2022 Sep 6:JCO2200365. doi: 10.1200/JCO.22.00365.
    

    >> Share

    
    July 2022
17. JOHANSSON A, Dar H, van 't Veer LJ, Tobin NP, et al
    Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.
    J Clin Oncol. 2022 Jul 21:JCO2102844. doi: 10.1200/JCO.21.02844.
    

    >> Share

    
    
18. LEE CH, Voss MH, Carlo MI, Chen YB, et al
    Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
    J Clin Oncol. 2022;40:2333-2341.
    

    >> Share

    
    June 2022
19. HOL JA, Kuiper RP, van Dijk F, Waanders E, et al
    Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
    J Clin Oncol. 2022;40:1892-1902.
    

    >> Share

    
    
20. GWEE YX, Chia DKA, So J, Ceelen W, et al
    Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis.
    J Clin Oncol. 2022 Jun 1:JCO2102745. doi: 10.1200/JCO.21.02745.
    

    >> Share

    
    April 2022
21. KURRECK A, Stintzing S, Modest DP
    Efficacy, Molecular Biology, Quality of Life, or Economic Aspects: What Do We Really FOCUS oN?
    J Clin Oncol. 2022;40:1260-1262.
    

    >> Share

    
    
22. CHAKRAVARTY D, Johnson A, Sklar J, Lindeman NI, et al
    Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.
    J Clin Oncol. 2022;40:1231-1258.
    

    >> Share

    
    February 2022
23. CARLOS RC, Obeng-Gyasi S, Cole SW, Zebrack BJ, et al
    Linking Structural Racism and Discrimination and Breast Cancer Outcomes: A Social Genomics Approach.
    J Clin Oncol. 2022 Feb 2:JCO2102004. doi: 10.1200/JCO.21.02004.
    

    >> Share

    
    December 2021
24. SABNIS HS, Shulman DS, Mizukawa B, Bouvier N, et al
    Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms.
    J Clin Oncol. 2021;39:3822-3828.
    

    >> Share

    
    November 2021
25. NAZHA A, Komrokji R, Meggendorfer M, Jia X, et al
    Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes.
    J Clin Oncol. 2021;39:3737-3746.
    

    >> Share

    
    October 2021
26. ADEMUYIWA FO, Salyer P, Tao Y, Luo J, et al
    Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists.
    J Clin Oncol. 2021 Oct 18:JCO2101426. doi: 10.1200/JCO.21.01426.
    

    >> Share

    
    September 2021
27. MASCARENHAS L
    A Step Forward in Realizing the Promise of Genomic Medicine for Childhood Rhabdomyosarcoma.
    J Clin Oncol. 2021;39:2851-2854.
    

    >> Share

    
    
28. SHERN JF, Selfe J, Izquierdo E, Patidar R, et al
    Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
    J Clin Oncol. 2021;39:2859-2871.
    

    >> Share

    
    April 2021
29. BERSANELLI M, Travaglino E, Meggendorfer M, Matteuzzi T, et al
    Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
    J Clin Oncol. 2021;39:1223-1233.
    

    >> Share

    
    
30. MURPHY AB, Abern MR, Liu L, Wang H, et al
    Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial.
    J Clin Oncol. 2021 Apr 9:JCO2002997. doi: 10.1200/JCO.20.02997.
    

    >> Share

    
    February 2021
31. CREW KD, Hershman DL
    Better Together: Clinical and Genomic Data to Inform Shared Decision Making.
    J Clin Oncol. 2021;39:545-547.
    

    >> Share

    
    January 2021
32. KUMAR R, Smith KS, Deng M, Terhune C, et al
    Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
    J Clin Oncol. 2021 Jan 27:JCO2001359. doi: 10.1200/JCO.20.01359.
    

    >> Share

    
    
33. KALINSKY K, Thomas A, Cescon DW
    On the Road to Precision: Understanding the Biology Driving Genomic Assays.
    J Clin Oncol. 2021;39:100-102.
    

    >> Share

    
    
34. GAJJAR A, Robinson GW, Smith KS, Lin T, et al
    Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
    J Clin Oncol. 2021 Jan 6:JCO2001372. doi: 10.1200/JCO.20.01372.
    

    >> Share

    
    November 2020
35. AMBROS IM, Tonini GP, Potschger U, Gross N, et al
    Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
    J Clin Oncol. 2020;38:3685-3697.
    

    >> Share

    
    October 2020
36. CROMBIE JL, Armand P
    Diffuse Large B-Cell Lymphoma's New Genomics: The Bridge and the Chasm.
    J Clin Oncol. 2020;38:3565-3574.
    

    >> Share

    
    July 2020
37. LONIAL S, Dhodapkar MV, Rajkumar SV
    Smoldering Myeloma and the Art of War.
    J Clin Oncol. 2020;38:2363-2365.
    

    >> Share

    
    
38. BUSTOROS M, Sklavenitis-Pistofidis R, Park J, Redd R, et al
    Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression.
    J Clin Oncol. 2020;38:2380-2389.
    

    >> Share

    
    May 2020
39. LIN DW, Zheng Y, McKenney JK, Brown MD, et al
    17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort.
    J Clin Oncol. 2020;38:1549-1557.
    

    >> Share

    
    
40. KURIAN AW, Katz SJ
    Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control.
    J Clin Oncol. 2020;38:1371-1374.
    

    >> Share

    
    
41. FREY MK, Kahn RM, Chapman-Davis E, Tubito F, et al
    Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.
    J Clin Oncol. 2020;38:1389-1397.
    

    >> Share

    
    April 2020
42. ROBINSON GW, Gajjar A
    Genomics Paves the Way for Better Infant Medulloblastoma Therapy.
    J Clin Oncol. 2020 Apr 30:JCO2000593. doi: 10.1200/JCO.20.00593.
    

    >> Share

    
    
43. TREON SP, Xu L, Guerrera ML, Jimenez C, et al
    Genomic Landscape of Waldenstrom Macroglobulinemia and Its Impact on Treatment Strategies.
    J Clin Oncol. 2020;38:1198-1208.
    

    >> Share

    
    March 2020
44. FREEMAN S, Craddock C
    Less Is Not Necessarily More: Toward a Rational Selection of the Conditioning Regimen in Acute Myeloid Leukemia.
    J Clin Oncol. 2020 Mar 2:JCO1903161. doi: 10.1200/JCO.19.03161.
    

    >> Share

    
    February 2020
45. HASSETT MJ, Somerfield MR, Baker ER, Cardoso F, et al
    Management of Male Breast Cancer: ASCO Guideline.
    J Clin Oncol. 2020 Feb 14:JCO1903120. doi: 10.1200/JCO.19.03120.
    

    >> Share

    
    January 2020
46. KONSTANTINOPOULOS PA, Norquist B, Lacchetti C, Armstrong D, et al
    Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
    J Clin Oncol. 2020 Jan 27:JCO1902960. doi: 10.1200/JCO.19.02960.
    

    >> Share

    
    December 2019
47. EGGENER SE, Rumble RB, Armstrong AJ, Morgan TM, et al
    Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.
    J Clin Oncol. 2019 Dec 12:JCO1902768. doi: 10.1200/JCO.19.02768.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share